+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Actelion Pharmaceuticals Ltd.  - logo

Actelion Pharmaceuticals develops drugs for pulmonary arterial hypertension treatments that cover the spectrum of diseases ranging from WHO functional class (FC) II through to FC IV, with oral, inhaled, and intravenous medications. Actelion has operative affiliates in over 30 countries. The company was founded in 1997 and is based in Allschwil, Switzerland. Actelion Pharmaceuticals Ltd. operates as a subsidiary of Actelion Ltd.

From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 pages
From
From
From
From
T-Cell Lymphoma Market 2019-2025 - Product Thumbnail Image

T-Cell Lymphoma Market 2019-2025

  • Report
  • September 2020
From
Global T-Cell Lymphoma Market & Clinical Pipeline Insight - Product Thumbnail Image

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

  • Drug Pipelines
  • March 2016
  • 168 Pages
From
From
From
From
From
From
From
From
From
Loading Indicator
adroll